Neuro Disorders Flashcards
Amyotrophic lateral sclerosis
ALS is a progressive motor neuron disease characterized by dysfunction of both upper motor neurons (UMNs) and lower motor neurons (LMNs) in the corticospinal and corticobulbar tracts, anterior motor horn cells, and bulbar motor nuclei
ALS Onset
55-75 years old
Few risk factors
Familial history may be a risk
ALS Presentation
Precise documentation of history of symptoms and exam is key
Early Lower Motor Neuron death = asymmetric weakness in limbs, foot drop, difficulty moving limbs
Early Upper Motor dysfunction = hypperreflexia, spasticity, Babinski sign, weakness, fasiculations
Bulbar Dysfunction = dysarthria, dysphagia, tongue atrophy, tongue irregular movement
ALS Diagnosis
diagnosis of ALS is usually made when there are widespread UMN and LMN signs in the absence of any electrophysiologic and pathologic signs of other disease processes as well as absence of neuroimaging evidence of other disease processes
Rule out heavy metal exposure, thyroid, CSF causes, electrolyte / vitamin issues, nerve conduction for parkinson
ALS Managment
Symptom Management
Riluzole - antiglutimate that improves survival, slows progression but liver damaging
Edaravone - reduces oxidative stress, infusion then injections, used as adjunct
SSRI/SNRI for dperession
Benzo to manage anxiety
Tizanidine and baclofen for spasticity
Poor life expectancy
Bell Palsy
acute, unilateral weakness or paralysis of the facial nerve, with an onset of less than 72 hours and unknown etiology, Bell palsy is the most commonly diagnosed peripheral facial nerve condition
Bell Palsy Presentation
Acute and progressive pain behind ear then facial paralysis
-smooth forehead, inability to close eye, asymmetric smile, tearing, drooling, tinnitus
History of recent infection or viral illness
Bell Palsy Diagnosis
routine diagnostic tests and imaging are not recommended for new-onset Bell palsy.
Rule out CVA/TIA and Lyme Disease
Refer if patient is pregnant, corneal abrasion, no improvement in 2 weeks, atypical presentation
Bell Palsy Treatment
Protection of the eye is critical
Corticosteroids within 72 hours of symptoms
Ischemic Stroke
In ischemic stroke, the patient usually has a single attack, and the entire event evolves within a few hours. However, the stroke may occur in a “stuttering” fashion, with intermittent progression or fluctuation of neurologic deficits that extends to maximal deficit over the first 72 hours
The classic visual disturbance (amaurosis fugax) is a transient, painless loss of vision, often described as a shade descending over the visual field.
Subarachnoid Hemorrhage
the clinical presentation is usually heralded by the abrupt onset of a severe headache (“the worst headache of my life”), nausea and vomiting, signs of meningeal irritation, and varying degrees of neurologic dysfunction. Loss of consciousness at the time of the initial event is common but is usually short-lived. Nearly 50% of patients with aneurysmal SAH give a history of atypical headaches occurring days to weeks before the definitive event.
Intracerebral Hemorrghage
no consistent warning or prodromal symptoms. In the majority of cases, the hemorrhage has its onset while the patient is up and active; onset during sleep is rare. The blood pressure is elevated in almost all cases. The neurologic signs and symptoms vary with the site and size of the extravasation of blood. The patient may lapse almost immediately into stupor and coma, with hemiplegia and steady deterioration to death during the next several hours. More often, the patient complains of a headache, followed within a few minutes by unilateral facial sag, slurred speech, weakness in an arm and leg, and eye deviation away from the paretic limbs. These events, occurring during a period of 5 to 30 minutes, strongly suggest intracerebral bleeding.
Dementia
dementia comprises several symptoms, including a progressive loss of memory and behavioral changes, which together interfere with independence in activities of daily living
Mild Cognitive Impairment
MCI is thought to be a transitional state between normal aging and dementia. Because individuals with MCI may progress to dementia at a rate of 10% to 15% a year, MCI is considered a risk factor for all types of dementia, and these patients need close monitoring and follow-up
Alzheimer’s Disease
Alzheimer’s disease is characterized by amyloid plaques and neurofibrillary tangles. Examinations of the brains of patients with Alzheimer’s disease show atrophy of the cerebral cortex that is usually diffuse but may be more pronounced in the frontal, temporal, and parietal lobes